Documents

This document provides you with key investor information about this Fund. It is not marketing material. The information is required by law to help you understand the nature and the risks of investing in this Fund. You are advised to read it so you can make an informed decision about whether to invest.

This document provides you with key information about this investment product. It is not marketing material. The information is required by law to help you understand the nature, risks, costs, potential gains and losses of this product and to help you compare it with other products.

INTERMEDE UCITS ICAV (an open-ended umbrella ICAV with segregated liability between its Funds under the laws of Ireland authorised and regulated by the Central Bank of Ireland pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations, 2011, as amended)

This Supplement contains specific information in relation to the Intermede Global Equity Fund (the “Fund”), a Fund of Intermede UCITS ICAV (the “ICAV”). It forms part of and must be read in the context of and together with the Prospectus of the ICAV dated 6 January 2022.

This Supplement contains information specific to investors in the United Kingdom regarding Intermede UCITS ICAV (the “ICAV”). It forms part of and must be read in conjunction with the prospectus of the ICAV dated 6 January 2022, as amended and supplemented from time to time (the “Prospectus”).

Intermede UCITS ICAV UK reporting fund status Report to Investors Reporting Period Ended 31 December 2022